Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saye Khoo

Showing results (201-210 of 282) with videos related to

Pageof 29
Sort By:
The Journal of Antimicrobial Chemotherapy|May 16, 2021
Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)Carolina Herrera, Julianne Lwanga, Ming Lee, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2010
Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan womenMohammed Lamorde, Pauline Byakika-Kibwika, Violet Okaba-Kayom, et al.
British Journal of Clinical Pharmacology|January 19, 2018
Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medicationsFiona Marra, Christoph Höner Zu Siederdissen, Saye Khoo, et al.
AIDS (London, England)|March 14, 2020
Plasma nucleotide reverse transcriptase inhibitor concentration and their associations with liver and renal parameters in people living with HIVXinzhu Wang, Marta Boffito, Laura Dickinson, et al.
The Journal of Infectious Diseases|January 11, 2019
HIV-Related Arterial Stiffness in Malawian Adults Is Associated With the Proportion of PD-1-Expressing CD8+ T Cells and Reverses With Antiretroviral TherapyChristine Kelly, Henry C Mwandumba, Robert S Heyderman, et al.
Pharmaceutics|June 24, 2022
Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin TissueLaura Else, Sujan D Penchala, Azure-Dee Pillay, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2011
Pharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: results of the ENCORE 2 studyLaura J Else, Akil Jackson, Rebekah Puls, et al.
British Journal of Clinical Pharmacology|May 14, 2011
Lopinavir/ritonavir population pharmacokinetics in neonates and infantsSaik Urien, Ghislaine Firtion, Suzanne T Anderson, et al.
AIDS (London, England)|January 26, 2024
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIVLena van der Wekken-Pas, Sylvia Nassiwa, Thokozile Malaba, et al.
The Journal of Infectious Diseases|April 21, 2021
T-Cell Homeostatic Imbalance in Placentas From Women With Human Immunodeficiency Virus in the Absence of Vertical TransmissionNadia M Ikumi, Komala Pillay, Tamara Tilburgs, et al.
Pageof 29

Showing results (201-210 of 282) with videos related to

Sort By:
Pageof 29
The Journal of Antimicrobial Chemotherapy|May 16, 2021
Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)Carolina Herrera, Julianne Lwanga, Ming Lee, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2010
Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan womenMohammed Lamorde, Pauline Byakika-Kibwika, Violet Okaba-Kayom, et al.
British Journal of Clinical Pharmacology|January 19, 2018
Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medicationsFiona Marra, Christoph Höner Zu Siederdissen, Saye Khoo, et al.
AIDS (London, England)|March 14, 2020
Plasma nucleotide reverse transcriptase inhibitor concentration and their associations with liver and renal parameters in people living with HIVXinzhu Wang, Marta Boffito, Laura Dickinson, et al.
The Journal of Infectious Diseases|January 11, 2019
HIV-Related Arterial Stiffness in Malawian Adults Is Associated With the Proportion of PD-1-Expressing CD8+ T Cells and Reverses With Antiretroviral TherapyChristine Kelly, Henry C Mwandumba, Robert S Heyderman, et al.
Pharmaceutics|June 24, 2022
Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin TissueLaura Else, Sujan D Penchala, Azure-Dee Pillay, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2011
Pharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: results of the ENCORE 2 studyLaura J Else, Akil Jackson, Rebekah Puls, et al.
British Journal of Clinical Pharmacology|May 14, 2011
Lopinavir/ritonavir population pharmacokinetics in neonates and infantsSaik Urien, Ghislaine Firtion, Suzanne T Anderson, et al.
AIDS (London, England)|January 26, 2024
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIVLena van der Wekken-Pas, Sylvia Nassiwa, Thokozile Malaba, et al.
The Journal of Infectious Diseases|April 21, 2021
T-Cell Homeostatic Imbalance in Placentas From Women With Human Immunodeficiency Virus in the Absence of Vertical TransmissionNadia M Ikumi, Komala Pillay, Tamara Tilburgs, et al.
Pageof 29